(SiFA)SeFe: A Hydrophilic Silicon-Based Fluoride Acceptor Enabling Versatile Peptidic Radiohybrid Tracers
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Sandra Deiser und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medicinal and Bioinorganic Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstr. 4…. Hauptthemen laut MEDLINE: Hydrophobic and Hydrophilic Interactions, Receptors, Somatostatin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
The radiohybrid (rh) concept to design targeted (and chemically identical) radiotracers for imaging or radionuclide therapy of tumors has gained momentum. For this strategy, a new bifunctional Silicon-based Fluoride Acceptor (SiFA) moiety (SiFA)SeFe was synthesized, endowed with improved hydrophilicity and high versatility of integration into rh-compounds. Preliminary radiolabeling and stability studies under different conditions were conducted using model bioconjugate peptides. Further, three somatostatin receptor 2 (sstR2)-targeted rh-compounds ((SiFA)SeFe-rhTATE1-3, TATE = (Tyr3)-octreotate) were developed. Compound (SiFA)SeFe-rhTATE3, enables labeling with 18F for PET imaging or chelation of 177Lu for therapy. The rh-compounds possess comparable receptor binding affinity and in vitro performance as good as the clinically proven gold standards. SstR2-specificity was further shown for (SiFA)SeFe-rhTATE2 using the chicken chorioallantoic membrane (CAM) model. The biodistribution of two compounds in mice showed high accumulation in tumors and excretion via the kidneys, demonstrating the clinical applicability of the (SiFA)SeFe moiety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chair of Medicinal and Bioinorganic Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstr. 4, 85748 Garching b. München, Germany.
- Chair of Pharmaceutical Radiochemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Walther-Meißner-Str. 3, 85748 Garching b. München, Germany.
- Institute of Silicon Chemistry, Department of Chemistry, School of Natural Sciences, Technical University of Munich, Lichtenbergstr. 4, 85748 Garching b. München, Germany.
- School of Biomedical Engineering and Imaging Sciences King's College London St Thomas' Hospital, London SE1 7EH, U.K.
ORCID-Profile: Sebastian Fenzl, Victor König, Marike Drexler, Timothy H Witney, Shigeyoshi Inoue, Angela Casini
Förderung
- Wellcome Trust
Zitieren
APA
Deiser, S., Fenzl, S., König, V., Drexler, M., Smith, L. M., George, M. E., Beck, R., Witney, T. H., Inoue, S., & Casini, A. (2024). (SiFA)SeFe: A Hydrophilic Silicon-Based Fluoride Acceptor Enabling Versatile Peptidic Radiohybrid Tracers. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00924
Vancouver
Deiser S, Fenzl S, König V, Drexler M, Smith LM, George ME, et al. (SiFA)SeFe: A Hydrophilic Silicon-Based Fluoride Acceptor Enabling Versatile Peptidic Radiohybrid Tracers. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00924
BibTeX
@article{Deiser2024,
author = {Deiser, Sandra and Fenzl, Sebastian and König, Victor and Drexler, Marike and Smith, Lydia M and George, Madeleine E and Beck, Roswitha and Witney, Timothy H and Inoue, Shigeyoshi and Casini, Angela},
title = {(SiFA)SeFe: A Hydrophilic Silicon-Based Fluoride Acceptor Enabling Versatile Peptidic Radiohybrid Tracers},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00924}
}
EUVIMED